Breast Cancer,HER2+ HER2DX Risk-Score In HER2+ BC Following Neoadjuvant And Adjuvant Anti-HER2-Based Treatment Oct 26, 2023
Breast Cancer,HER2+ Margetuximab vs Trastuzumab in Pretreated ERBB2-Positive Advanced Breast Cancer Jun 08, 2023
Breast Cancer,HER2+ Examining the Potential of Margetuximab in the Treatment of HER2+ Metastatic Breast Cancer May 19, 2023
Breast Cancer,HER2+ Phase 3 PRECIOUS Study: Pertuzumab Retreatment Benefits for HER2+ Cancer Patients Mar 28, 2023
Breast Cancer,HER2+ Fam-Trastuzumab Gains FDA Approval for HER2-Low Breast Cancer Treatment Mar 14, 2023
Breast Cancer,HER2+ HER2DX Test Correlates with Trastuzumab/Pertuzumab Therapy in HER2+/HR+ Breast Cancer Mar 14, 2023
